Philippe Lefrancois
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Philippe Lefrancois currently holds the positions of Director at Defence Therapeutics Inc since 2024, Research Director-Dermatology Division at McGill University, and Member of the Quebec Cancer Consortium.
The education history includes a doctorate from the University of Montréal conferred in 2016 and a doctorate from Yale University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/12/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| DEFENCE THERAPEUTICS INC. | Directeur/Membre du Conseil | 27/09/2024 |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Montréal
University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Defence Therapeutics Inc
Defence Therapeutics Inc Pharmaceuticals: MajorHealth Technology Engages in the research and development of anti-body drug conjugates | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national